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Abstract: 
 
Benefits of eicosapentaenoic acid (EPA) can be enhanced by raising their 
bioavailability through microencapsulation.Pollen can be emptied to form hollow 
shells, known as exines, and then used to encapsulate material,such as oils in a dry 
powder form.6 healthy volunteers ingested 4.6 g of fish oil containing 20% EPA in 
the form of ethyl-ester first alone and then as 1:1 microencapsulated powder of exines 
and fish oil.Serum bioavailability of EPA was measured by area under curve (AUC0-
24).The mean AUC0-24 of EPA from ethyl-ester with exine(M=19.7,SD=4.3)was 
significantly higher than ethyl-ester without exines(M=2,SD=1.4,p<0.01).The 
bioavailability of EPA is enhanced by encapsulation by pollen exines. 
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Introduction: 
Eicosapentaenoic acid (EPA) and docosahexaenoic acid, the main long chain 
polyunsaturated fatty acids (LCPUFA), can only be obtained from a fish and shellfish  
rich diet. Recent trials have shown that EPA in the form of ethyl ester added to statins 
in hypercholesterolaemic Japanese resulted in 19% relative risk reduction in major 
cardiovascular events[1]. Instead of being taken to prevent nutritional deficiency they 
are now being taken to prevent diseases with an inflammatory pathology, including 
cardiovascular diseases[2]. One strategy to raise plasma concentration of LCPUFA is 
to optimise their absorption and bioavailability.  
Microencapsulation has been used to mask unpleasant taste in food sciences as well as 
to protect against light and airborne oxidation[3, 4]. Pollen and plant spores, from 
mosses and ferns have an outer layer skeleton known as the exine that is composed of 
sporopollenin[5,6]. Exine microencapsulation technology has been shown to provide 
excellent taste masking for fish oils[7], they have been investigated as use as a 
contrast agent[8] , and attempts have been made to introduce them as a novel method 
of oral delivery of substances into the blood stream as opposed to the parenteral 
route[9].  
In this study we have investigated whether encapsulating the ethyl ester form of fish 
oil with exine microcapsules extracted from readily available and renewable 
Lycopodium clavatum spores, can enhance the bioavailability, measured by area under 
the curve, of EPA delivered as ethyl ester alone.  
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Experimental procedure: 
This was an open labelled study. Six healthy volunteers without concomitant illnesses 
or medications were recruited from an advertisement for healthy volunteers in Hull 
University and Hull Royal Infirmary. The study protocol was approved by the Hull 
and East Riding Research Ethics Committee. All subjects received dietary counselling 
by an academic dietician to avoid fish or omega-3 fatty acid intake in their diet two 
weeks before and during the course of the trial. Coffee, flax seed and alcohol were 
avoided a day prior, during and a day after each visit. A run in period of 1 week was 
followed by 2 visits with 3 weeks between-visits during the wash-out period. Each 
subject ingested 4.6 grams of fish oil containing 20% of EPA in the form of the ethyl 
ester at each visit. In the first visit the fish oil was given in the form of a liquid 
immediately after defrosting. In the second visit the fish oil was encapsulated into 
exines and the subsequent powder was ingested. Blood samples were taken at baseline 
to quantify serum EPA and then at 2, 4, 6, 8 and 24 hours from ingesting the fish oil. 
Serum was instantly separated by centrifugation at 2000 g, and stored at –80 ºC before 
batch analysis of total serum fatty acid compositions by the Nutrition Group, Institute 
of Aquaculture, University of Stirling, Stirling UK. 0.5 ml serum was extracted by the 
Folch et al. method [10,11], using chloroform/methanol (C/M; 2:1 v/v). The extracted 
lipid was dissolved in 0.8 ml of C/M, 2:1 v/v and dried under nitrogen in a  pre-
weighed glass vial,was and desiccated for 16h. Final lipid extracts were re-suspended 
in C/M (2:1 v/v) + 0.01% (w/v) butylated hydroxytoluene (BHT), at a concentration 
of 10 mg/ml and stored at -70 ºC. 
Fatty acid methyl esters (FAME) were prepared by acid-catalysed transesterification 
of 0.5 mg of total lipid and 50 µg of 17:0 internal standard in 2 ml of 1% (v/v) H2SO4 
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in methanol at 50 ºC overnight[12]. Samples were neutralised with 2% KHCO3 and 
extracted twice with 5 ml isohexane/diethyl ether (1:1 v/v) + BHT and finally 
dissolved in 0.3 ml of isohexane prior to FAME analysis.  
Measurement of serum fatty acids 
FAME were separated and quantified by glc (Fisons 8160, Carlo Erba, Milan, Italy) 
using a 60 m × 0.32 mm × 0.25 µm film thickness capillary column (ZB Wax, 
Phenomenex, Macclesfield, England). Hydrogen was used as carrier gas (flow rate of 
4.0 ml/min) and the temperature programme was from 50 to 150 ºC at 40 ºC/min then 
to 195 ºC at 2 ºC/min and finally to 215 ºC at 0.5 ºC/min. FAME were identified using 
well characterised in house standards and commercial FAME mixtures (Supelco™ 37 
FAME mix, Sigma-Aldrich Ltd., Gillingham, England). Blood was withdrawn after 
30 minutes and examined under a confocal microscope to investigate for the presence 
of exines, which are naturally fluorescing  
Fish oil supplements were provided by Croda Europe, Goole, UK. Each vial had 4.6 
grams of fish oil containing 20% EPA in the form of its ethyl ester. They were 
shipped in dark containers and kept in a –20 ºC freezer until ready for defrosting in 
visit 1. In visit 2, the defrosted oil was encapsulated with 4.6 grams of exines no more 
than 24 hours prior to ingestion and the dark container was filled with nitrogen to 
prevent oxidation. Exines extracted from Lycopodium clavatum spores were supplied 
by Sporomex Ltd, UK, and were prepared as detailed previously[7]. 
Microencapsulation was performed by mixing exines with oil (1:1 weight for weight) 
by gently stirring to form a homogeneous paste that was then subjected to a vacuum 
(ca. 10hPa) for 2h to facilitate passive loading of oil into the particles through the 
nano-porous sporopollenin walls.  
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Area under the curve (AUC0-24h) was used to determine the bioavailability of EPA 
from the different supplements. The mean AUC0-24h for EPA was calculated using the 
linear trapezoid method and baseline levels were normalised to zero. We also 
observed visually the time of the maximum concentration (T max). Comparisons of 
mean AUCs and Tmax with and without exines were made using paired sample t-test 
via SPSS version 15. 
 
 
Results: 
The two male and four females’ demographics are summarised in Table 1. The 
baseline EPA percentage of total fatty acids in the six subjects were 0.69+/- 0.1% 
which was comparable to that reported in another study with healthy volunteers[13]. 
The mean concentration of EPA in mg/100ml at baseline (2.15 +/-0.6) and after 
washout (2.0 +/- 0.6) was not different using paired t test (p=0.49). The mean AUC of 
EPA from ethyl ester with exine (M=19.7, SD=4.3) was significantly higher than that 
obtained from ethyl ester without exines (M=2, SD=1.4, p<0.01). When the mean 
concentration of EPA in serum over time was plotted, after subtracting the mean sera 
concentrations of the respective time from the mean baseline concentration, it was 
evident that microencapsulation in exines had significantly enhanced the EPA 
absorption as reflected by the serum concentration (Figure 1). The mean Time of 
maximum (T max) concentration for EPA when fish oil was encapsulated with exines 
(M=7.6 hours) was not different from the maximum concentration without exines 
(M=6.8, p=0.4), results not shown. Confocal microscopy (Bio-Rad Radiance 2100 
laser scanning microscope equipped with Ar (488nm), Green HeNe (563nm) and Red 
diode (637nm) laser lines connected to a Nikon TE-2000E inverted microscope) 
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showing an empty fluorescent exine before ingestion and an apparently intact exine in 
blood plasma after ingestion (Figure 2). Micrographs of oil filled exines before 
ingestion and those recovered from blood, following ingestion, were also obtained 
using a Leica Cambridge Stereoscan 360 Scanning Electron Microscope (SEM) 
operated by Tony Sinclair, Institute of Chemistry for Industry, University of Hull, 
performed the SEM (Figure 3). 
 
Discussion: 
In this study, there was a significant rise in the bioavailability of EPA as measured by 
AUC0-24h when the ethyl ester form of fish oil was encapsulated into the novel exine 
microcapsules, which has not been reported before. Previous studies have focussed on 
the encapsulation of fish oil to preserve its qualities and prevent oxidation [4], rather 
than to enhance bioavailability. Although there are no previous studies on the effect of 
the bioavailability of EPA encapsulated into exines, encapsulation technology is 
commonly used in pharmaceutical preparations to improve bioavailability. For 
example, the use of a mixture of wax and fat has been used to achieve controlled drug 
release in the circulation[14] while the use of microspheres to produce mucoadhesive 
polymers can help maintaining intimate contact with the mucosa of the 
gastrointestinal tract thereby achieving improved bioavailability[15]. Exines have 
been used as a natural substance to mask-taste but this is the first pilot study to 
investigate its potential use to improve bioavailability of orally ingested fish oil in the 
ethyl ester form[7]. The mechanism by which exine microencapsulation can enhance 
oil absorption is unclear, but might be due to the protective structure of fish oil-
enriched exines whereby the whole unit could travel unhindered through the mucosal 
lining without releasing its inner core until entering the circulation. This increase in 
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bioavailability was independent of the Tmax that is a measure of the time to achieve the 
maximum concentration, suggesting that exines may enhance the absorption at the 
early stages and continue to do so throughout the 24 hour period, in contrast to a 
natural slower pace of absorption of EPA in the early period of supplementation.  
Whilst it is difficult to cost this method, it is expected  there would be no significant 
extra cost compared with other  microencapsulation processes; however, no other 
technique has the advantage of anti-oxidant properties giving a long shelf-life, has 
been shown to taste mask and also to have a relatively high loading level. The 
preparation of the exines is simple and inexpensive with the total cost of the 
microencapsulation within the exines being less with readily available pollens such as 
that for rye or maize. 
 
The major limitation to this pilot study is the small number of participants. However, 
as a proof of hypothesis, our results were highly significant and further in vitro and in 
vivo studies are warranted to explain this phenomenon.  
 
In summary, this study showed that exines obtained from Lycopodium clavatum 
spores encapsulating fish oil in the ethyl ester are associated with an improvement in 
LCPUFA bioavailability as measured by the AUC0-24h, that may be due to the oil 
being transported into the blood stream more efficiently by the intact exines.  
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